US filing analysis · 10-K
Sorted by SEC acceptance time (filing date when unavailable). Page 22 · 30 shown · up to 30 per page
ED
Con Edison said it completed the sale of all of the stock of the Clean Energy Businesses on March 1, 2023, and that its 2023 net income for common stock included a gain on the sale of $767 million ($2.21 a share, after tax).
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 15, 2024
Consolidated EdisonED$119.36+0.23%
DD
DuPont said net sales for fiscal 2023 were $12.1 billion, down 7% from $13.0 billion a year earlier. The company cited a 8% decrease in volume and an unfavorable currency impact of 1% as factors, partly offset by a 2% increase in local price and product mix.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 15, 2024
DuPontDD$145.43-2.85%
COP
The company said total annual production in 2023 was 1,826 MBOED, an increase of 88 MBOED (5%) from 2022, and that cash provided by operating activities was $20.0 billion, lower than the $28.3 billion in 2022.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 15, 2024
ConocoPhillipsCOP$136.12+0.84%
CHD
The company said net sales for 2023 grew 9.2% over 2022, while operating margin was 18.0% (2022 11.1%) and diluted earnings per share were $3.05 (2022 $1.68). Operating margin for 2022 included a non-cash Flawless intangible asset impairment charge of $411.0.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 15, 2024
Church & DwightCHD$110.84+1.06%
BE
Bloom Energy said total revenue for fiscal 2023 increased $134.3 million (11.2%) from the prior year. Product revenue rose $94.6 million, service revenue $32.1 million, electricity revenue $7.0 million and installation revenue $0.7 million.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 15, 2024
Bloom EnergyBE$142.39-15.30%
AIZ
The company said consolidated net income rose $642.5 million to $276.6 million in 2023 (Twelve Months 2023) from $365.9 million in 2022, or 132%, citing higher Global Housing segment earnings and lower reportable catastrophes.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 15, 2024
AssurantAIZ$316.65+0.20%
WAB
The company said that 2023 net sales rose $1.32 billion (15.7%) from 2022 to $9.68 billion. Of this, organic sales growth was $1.20 billion, attributable to both the Freight and Transit Segments.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
WabtecWAB$269.31-4.07%
SYK
The company said Stryker's 2023 net sales rose 11.1% as reported, with net earnings of $3,165 and net earnings per diluted share of $8.25. Adjusted net earnings were $4,066 and adjusted net earnings per diluted share were $10.60, up 13.5%.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
StrykerSYK$310-0.98%
OXY
The company said that the average annual WTI crude price per barrel in 2023 fell to $77.64 from 2022’s $94.23, and the average annual Brent price fell to $82.25 from 2022’s $98.83.
US filing analysisUS10-K · Annual reportPublished Nov 1, 2026 (UTC)SEC filing date Feb 14, 2024
Occidental PetroleumOXY$53.9+0.17%
MCO
Moody's said global MA revenue rose 10%, with growth in both the U.S. (9%) and internationally (12%), and ARR increased 10%. The company cited demand for KYC solutions, insurance products and SaaS-based banking offerings as drivers of growth.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
Moody'sMCO$466.83-1.06%
GPN
The company said consolidated revenues for 2023 rose to $9,654.4 million, up 7.6% from $8,975.5 million in the prior year. It cited higher transaction volumes, including from the EVO business, as the main factor for the increase, and said the effect of the divested businesses partially offset it.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
Global PaymentsGPN$91.83+9.95%
ES
The company said it recorded a net loss of $442.2 million ($1.26 per share loss) in 2023, compared with net income of $1.40 billion ($4.05 per share) in 2022. The company said that excluding after-tax offshore wind impairment charges of $1.95 billion and other items, its non-GAAP earnings were $1.52 billion ($4.34 per share).
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
Eversource EnergyES$71.04+0.55%
EQT
EQT said net income attributable to EQT Corporation for 2023 was $1,735 million ($4.22 per diluted share), down from $1,771 million ($4.38) in 2022. The company attributed the decrease mainly to lower sales of natural gas, NGLs and oil.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
EQTEQT$48.89-0.83%
DVA
The company said its operating cash flow was $2,059 million in 2023 and $1,565 million in 2022. It cited improved operating results, faster cash collections on accounts receivable and lower cash taxes paid as factors that increased cash flow, which it said were partially offset by higher interest payments.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
DaVitaDVA$161.03+3.00%
CTSH
Cognizant said its full-year 2023 revenue declined $75 million, or 0.4%, from the prior year, and fell 0.3% on a constant currency basis. The company cited weakness in the banking sector as the reason for the revenue decline in its Financial Services segment.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
CognizantCTSH$58.08+3.14%
CSX
CSX said its full-year 2023 revenue fell to $14.7 billion, down $196 million (1%) from the prior year, operating income declined $462 million to $5.6 billion (8%), and diluted earnings per share fell $0.10 to $1.85 (5%).
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
CSXCSX$49.1-1.76%
CRL
The company said its revenue for fiscal 2023 was $4.1 billion, up $153.3 million (3.9%) from $4.0 billion in fiscal 2022. Operating income was $617.3 million, with an operating margin of 14.9%, lower than $651.0 million (16.4%) in fiscal 2022.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
Charles River LaboratoriesCRL$314.32-4.15%
BIIB
The company said global TECFIDERA revenue fell $1,443.9 million from 2023 to 2022, or 29.9%, to $1,012.5 million from $431.4 million, citing lower demand from multiple generic entrants in North America, Brazil and certain E.U. countries.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
BiogenBIIB$249.84+1.10%
AWK
The company said diluted earnings per share (GAAP) were $4.90 in 2023, up $0.39 from $4.51 in 2022. It cited the implementation of new rates in the Regulated Businesses as the primary driver, offset somewhat by higher operating costs and higher pension costs.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
American Water WorksAWK$149.53+0.84%
AMGN
Amgen said total product sales rose in 2023, driven mainly by volume growth for Repatha, TEZSPIRE, EVENITY, Prolia and BLINCYTO, and by $954 million in product sales from the Horizon acquisition from October 6, 2023 through December 31. It said declines in net selling prices for certain products partly offset these gains.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
AmgenAMGN$436-0.64%
AIG
AIG said Net income attributable to AIG common shareholders decreased $6.6 billion. The largest pre-tax decline was a $9.5 billion drop in Net realized gains on the Fortitude Re funds withheld embedded derivative, which the company attributed to interest rate movements.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 14, 2024
American International GroupAIG$79.68+0.23%
WM
The company said revenue tied to yield in its Recycling Processing and Sales segment decreased by $308 million in 2023, and WM Renewable Energy segment revenue decreased by $73 million. The company said the average market price for single-stream recycled commodities fell 40% in 2023.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 13, 2024
Waste ManagementWM$239.63+0.40%
MAR
The company said worldwide RevPAR rose 14.9% in 2023 compared with 2022, reflecting ADR growth of 5.8% and occupancy improvement of 5.5 percentage points. International segment RevPAR increased 32.6%, and U.S. & Canada RevPAR increased 8.9%.
US filing analysisUS10-K · Annual reportPublished Nov 1, 2026 (UTC)SEC filing date Feb 13, 2024
Marriott InternationalMAR$406.92-1.72%
MA
Mastercard said net revenue for 2023 increased 13% from 2022, and rose 13% on both an as adjusted and currency-neutral basis. The company cited growth in its payment network and value-added services and solutions as the drivers of the increase.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 13, 2024
MastercardMA$629.6+0.49%
LII
The company said its net sales rose 6% in 2023 compared with 2022, with favorable mix of 5% and favorable price of 5% partly offset by a 4% decline in sales volume. Gross profit margin rose 390 basis points to 31.1% in 2022 (27.2% in the prior year).
US filing analysisUS10-K · Annual reportPublished Nov 1, 2026 (UTC)SEC filing date Feb 13, 2024
Lennox InternationalLII$334.49-2.37%
LDOS
The company said revenue for fiscal 2023 increased $1.0 billion, or 7%, from fiscal 2022. It cited program wins, a net increase in volumes on certain programs and a net increase in revenues from business acquisitions as drivers of the increase. It said the completion of certain contracts partially offset the increase.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 13, 2024
LeidosLDOS$122.21-2.04%
INCY
Incyte said it recorded net income of $597.6 million ($2.65 per diluted share) for the fiscal year ended December 31, 2023, compared with $340.7 million ($1.52 per diluted share) for 2022.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 13, 2024
IncyteINCY$114.63-1.07%
HWM
The company said its Sales rose to $6,640 in 2023 from $5,663 in 2022, an increase of $977, or 17%. It said sales in the commercial aerospace market grew 24%. The company also cited favorable product pricing of $105 and an increase in material cost pass through of $90 as factors.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 13, 2024
Howmet AerospaceHWM$209.16-4.13%
FE
The company said its investments in 2023 totaled $3.7 billion, which was $300 million above its original plan. Through the Energize program Energize365, the company expects approximately $26 billion in system-wide capital investments from 2024 through 2028, consisting of Distribution 29%, Integrated 39% and Stand-Alone Transmission 32%, it explained.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 13, 2024
FirstEnergyFE$47.03-0.21%
BMY
The company said revenues for 2023 decreased 2%, primarily due to lower Revlimid sales from generic erosion and higher free drug product provided to Revlimid and, to a lesser extent, Pomalyst patients through the Bristol Myers Squibb Patient Assistance Foundation. It cited higher sales of the New Product Portfolio and In-Line Products (primarily Opdivo) as partially offsetting the decline.
US filing analysisUS10-K · Annual reportPublished Oct 24, 2026 (UTC)SEC filing date Feb 13, 2024
Bristol Myers SquibbBMY$58.8+0.79%
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.